Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
January 1, 1992
Evaluation of medical students' hospital training: interest of students' essays
P Soubeyran, A Ravaud, L Cany, et al.
Journal of Surgical Oncology
|
June 11, 1999
Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients
L Cany, E Stoeckle, J M Coindre, et al.
British Journal of Cancer
|
December 1, 1993
Expression of MDR1/P glycoprotein in human sarcomas
B Vergier, L Cany, F Bonnet, et al.
Bulletin Du Cancer
|
January 1, 1992
[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]
L Cany, N B Bui, E Stöckle, et al.
Bulletin Du Cancer
|
October 16, 1999
[Adult's anaplastic CD30+ large cell lymphomas]
L Cany, P Soubeyran, V Boulanger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
Y Bécouarn, P Senesse, S Thézenas, et al.
Psycho-Oncology
|
February 26, 2016
Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy
S Duc, M Rainfray, P Soubeyran, et al.
British Journal of Cancer
|
February 1, 1995
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma
A Ravaud, E Legrand, M M Delaunay, et al.
British Journal of Cancer
|
December 17, 2003
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial
A Ravaud, N Trufflandier, J M Ferrière, et al.
Bulletin Du Cancer
|
November 1, 1991
[Adverse effects of interleukin 2]
A Ravaud, S Negrier, F Lakdja, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
January 1, 1992
Evaluation of medical students' hospital training: interest of students' essays
P Soubeyran, A Ravaud, L Cany, et al.
Journal of Surgical Oncology
|
June 11, 1999
Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients
L Cany, E Stoeckle, J M Coindre, et al.
British Journal of Cancer
|
December 1, 1993
Expression of MDR1/P glycoprotein in human sarcomas
B Vergier, L Cany, F Bonnet, et al.
Bulletin Du Cancer
|
January 1, 1992
[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]
L Cany, N B Bui, E Stöckle, et al.
Bulletin Du Cancer
|
October 16, 1999
[Adult's anaplastic CD30+ large cell lymphomas]
L Cany, P Soubeyran, V Boulanger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
Y Bécouarn, P Senesse, S Thézenas, et al.
Psycho-Oncology
|
February 26, 2016
Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy
S Duc, M Rainfray, P Soubeyran, et al.
British Journal of Cancer
|
February 1, 1995
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma
A Ravaud, E Legrand, M M Delaunay, et al.
British Journal of Cancer
|
December 17, 2003
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial
A Ravaud, N Trufflandier, J M Ferrière, et al.
Bulletin Du Cancer
|
November 1, 1991
[Adverse effects of interleukin 2]
A Ravaud, S Negrier, F Lakdja, et al.
Page
of 2